Modified Fatigue Impact Scale (MFIS)

Overview

The Modified Fatigue Impact Scale (MFIS) is a 21-item self-report questionnaire that measures how much fatigue has affected a person’s physical, cognitive, and psychosocial functioning over the preceding four weeks. Rather than asking simply how tired someone feels, it captures fatigue’s functional impact — the workload reductions, concentration lapses, and social withdrawal that fatigue can drive day to day.

The MFIS is a shortened, more clinically practical derivative of the original 40-item Fatigue Impact Scale, and has become one of the most widely used fatigue outcome measures in multiple sclerosis care, while also seeing use in other conditions where fatigue is a prominent and disabling symptom.

History

The MFIS was adapted from the original Fatigue Impact Scale developed by John D. Fisk and colleagues, first published in 1994 in Clinical Infectious Diseases in the context of chronic fatigue syndrome. The Multiple Sclerosis Council for Clinical Practice Guidelines later condensed the instrument into the 21-item Modified Fatigue Impact Scale as part of its 1998 evidence-based management strategies for fatigue in multiple sclerosis, retaining the three-domain structure — physical, cognitive, and psychosocial — while making the tool quicker to administer in routine clinical settings.

Since then, the MFIS has been extensively validated and is recommended by MS clinical practice guidelines as a standard outcome measure, and has also been adopted in research and clinical practice for other conditions where fatigue is a major contributor to disability, including post-concussion syndrome, Parkinson’s disease, and chronic dizziness.

Indications

The MFIS is used wherever fatigue-related functional impact needs to be screened for, quantified, or tracked over time:

• Multiple sclerosis, where it is a recommended standard outcome measure for one of the most common and disabling MS symptoms.
• Post-concussion and mild traumatic brain injury, where fatigue frequently persists alongside — or independently of — other post-concussion symptoms.
• Chronic dizziness and vestibular disorders, where cognitive fatigue (“brain fog”) often compounds physical symptoms and limits rehabilitation participation.
• Parkinson’s disease and other neurological conditions, where fatigue is common but easily overlooked relative to motor symptoms.
• Chronic illness and long-COVID populations, where fatigue is often the most functionally limiting symptom.
• Monitoring treatment response, whether pharmacological, rehabilitative, or lifestyle-based, through repeated administration over a course of care.

How It’s Scored

Each of the 21 items is rated on how often fatigue has affected the respondent that way over the past four weeks, from 0 (never) to 4 (almost always). The total score is the sum of all 21 items, giving a range from 0 to 84, where higher scores indicate greater fatigue-related impact.

The items are drawn from three subscales, which can also be scored separately:

• Physical subscale (9 items) — items 1, 5, 7, 8, 10, 11, 14, 15, 18.
• Cognitive subscale (10 items) — items 2, 3, 4, 6, 12, 13, 16, 17, 19, 20.
• Psychosocial subscale (2 items) — items 9 and 21.

Interpreting the total score

There is no single universally adopted severity banding for the MFIS total score. Research in multiple sclerosis populations has commonly used a threshold of 38 or higher (out of a possible 84) to flag a significant impact of fatigue on daily function, though this cut-point was derived in MS cohorts and should be applied cautiously in other populations. In practice, the MFIS is most often used to track change in an individual over time — through a course of treatment or rehabilitation — rather than to classify a single score into a fixed severity category.

What It Tells the Clinician

• Separates fatigue impact from fatigue intensity. Two patients reporting similarly “tired” may have very different functional impact — one may still work and socialise, another may have withdrawn from both — and the MFIS captures that difference.
• Distinguishes physical from cognitive fatigue. Subscale scores can reveal whether fatigue is limiting a patient primarily through physical exhaustion, cognitive slowing and concentration difficulty, or both — informing whether physical pacing strategies, cognitive rehabilitation, or both are indicated.
• Surfaces psychosocial withdrawal. The two psychosocial items flag when fatigue is driving reduced social participation, a pattern linked to isolation and lower quality of life if left unaddressed.
• Complements physical and cognitive test batteries. In conditions like MS, post-concussion syndrome, and Parkinson’s disease, the MFIS adds a self-reported functional layer that objective testing alone doesn’t capture.
• Tracks change over a course of care. Because it’s quick to re-administer, the MFIS is well suited to monitoring whether fatigue-management strategies, medication changes, or rehabilitation are translating into real functional improvement.

References

1. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18(Suppl 1):S79-S83.
2. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and Multiple Sclerosis: Evidence-Based Management Strategies for Fatigue in Multiple Sclerosis. Paralyzed Veterans of America; 1998.
3. Larson RD. Psychometric properties of the Modified Fatigue Impact Scale. Int J MS Care. 2013;15(1):15-20.